Results 31 to 40 of about 13,714 (298)
eJournal of Oral Maxillofacial Research, 2017 Objectives: Osteonecrosis of the jaws is a side effect associated with the use of bisphosphonates. Using histologic analysis, this study aimed to evaluate the influence of microbial colonies in the development of osteonecrosis in the jaws of rats ...
Felipe M. Silveira +3 more
doaj +1 more source
The World Journal of Men's Health, 2022 Patients with prostate cancer (PCa) on androgen-deprivation therapy (ADT) are at high risk of osteoporosis and fragility fractures. We aimed to provide some practical insights into the delivery of optimal bone health care for PCa patients, particularly
Enrique Casado +5 more
doaj +1 more source
Designing a new molecular probe : the potential role for Tilmanocept (Lymphoseek) in the assessment of patients with painful hip and knee joint prostheses [PDF]
, 2017 There is a long history of nuclear medicine developments in orthopaedics beginning in the early 20th century. Technetium-99m (99mTc) has a short half-life of six hours, emits 140 keV gamma rays and is the most widely used isotope, imaged with the Anger ...
Adesanya, Olu. O. +1 more
core +2 more sources
, 2014 Eight new transition metal diphosphonates, namely, [Mn(H2L)(H2O)2][(H2O)2] (1), [Co(H2O)6][H2L][(H2O)2] (2), [Co(H2O)6][(H3L)2][(H2O)2] (3), [Ni(H2O)6][H2L][(H2O)2] (4), [Cu(H2L)][(H2O)2] (5), [Zn(H2O)6][(H3L)2][(H2O)2] (6), [Zn(H2L)(H2O)2] (7) and [Cd ...
Sifu Tang +4 more
semanticscholar +1 more source
What do we know about atypical femoral fractures? Insights and enigmas [PDF]
, 2011 Although the existence of atypical femoral fractures is well established and bisphosphonate therapy is thought to be a major risk factor, the underlying mechanisms are poorly understood.
B. Cortet, M. Audran, T. Thomas
core +3 more sources
A rat model of thyroid hormone-induced bone loss: Effect of antiresorptive agents on regional bone density and osteocalcin gene expression [PDF]
, 1994 Thyroid hormone has been shown to stimulate bone resorption. Both endogenous hyperthyroidism and exogenous thyroxine suppressive therapy have been associated with reduction in bone mineral density (BMD), but the patholophysiology of thyroxine-induced ...
Kung, AWC, Ng, F
core +1 more source
Frontiers in PharmacologyObjectiveThere is currently no consensus on whether the combination therapy of Vitamin D (VitD) and bisphosphonates offers superior efficacy compared to monotherapy in the treatment of postmenopausal osteoporosis.
Yuangui Yang +3 more
doaj +1 more source
In vitro and in vivo evaluation of superparamagnetic iron oxide nanoparticles coated by bisphosphonates: the effects of electrical charge and molecule length. [PDF]
, 2013 Physicochemical coating properties are often considered to be determining factors for in vivo characteristics of superparamagnetic iron oxide nanoparticles, used as contrast agent in Magnetic Resonance Imaging (MRI). To investigate the electrical charge (
A. Karimi +6 more
core +3 more sources
Surface chemistry of heterobimetallic Ge-M (M = Mo, W) complexes in zeolite Y. [PDF]
, 1991 The intrazeolite chemistry of the two germylene complexes Cl2CTHF)GeM(CO)5 (M = Mo, W) was studied with x-ray absorption spectroscopy (Ge, Mo, W edge EXAFS) and in-situ FTIR/TPD-MS techniques.
Bein, Thomas +2 more
core +1 more source
DIPHOSPHONATES IN PAGET'S DISEASE
The Lancet, 1974 Abstract The diphosphonate, sodium etidronate (disodium ethane-1-hydroxy-1,1-diphosphonate) (E.H.D.P.), which inhibits the growth and dissolution of calcium phosphate crystals in vitro, was given at doses of 0, 1, 5, 10, or 20 mg. per kg. per day for up to 6 months to forty-seven patients with Paget's disease of bone.
Russell, R +4 more
openaire +2 more sources